News

Coherus Oncology has introduced the non-proprietary name tagmokitug for its anti-CCR8 monoclonal antibody and published preclinical and translational clinical...

Soleno Therapeutics has published the pivotal randomized withdrawal data for VYKAT XR (diazoxide choline extended-release) in the Journal of...

Syndax Pharmaceuticals will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, following a year...

Halozyme Therapeutics and Skye Bioscience have signed a non-exclusive global collaboration and license agreement enabling Skye to use Halozyme’s...

Medicus Pharma has consolidated financial and operational leadership by appointing President Carolyn Bonner as Chief Financial Officer, following the...

INVO Fertility has realigned its leadership to accelerate a clinic-focused growth strategy. Terah Krigsvold, previously the company’s controller, has...

Nicox has repaid all secured debt owed to Kreos Capital and secured up to €4 million in new unsecured...

Mesoblast has reshaped its board as it transitions from development to commercialization, appointing Philip Facchina as non-executive chair and...

Mesoblast has reshaped its board as it pivots from development to commercial execution following its first FDA approval and...

Zealand Pharma has set a 2030 agenda to become a next‑generation metabolic health leader, targeting five product launches, more...